Related Experiment Video
Updated: Apr 23, 2026
09:36
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
2.5K
[Contraindications to succinylcholine in the intensive care unit. A prevalence study]
T Muñoz-Martínez1, I Garrido-Santos1, R Arévalo-Cerón1
1Servicio de Medicina Intensiva, Hospital Universitario de Cruces, Baracaldo, Vizcaya, España.
Medicina Intensiva
|September 21, 2014
Summary
Succinylcholine use in ICUs is discouraged due to frequent contraindications. Over 70% of patient stays had reasons to avoid this drug, increasing complication risks.
Area of Science:
- Critical Care Medicine
- Pharmacology
- Anesthesiology
Background:
- Succinylcholine is a common neuromuscular blocking agent.
- Its use in intensive care units (ICUs) may be limited by patient-specific contraindications.
- Understanding these contraindications is crucial for safe medication practices.
Purpose of the Study:
- To determine the prevalence of contraindications to succinylcholine in patients admitted to the ICU.
- To identify specific contraindications and associated patient variables.
- To inform clinical decision-making regarding succinylcholine use in critically ill patients.
Main Methods:
- Observational study in a general adult ICU.
- Analysis of 657 patient stays over 30 consecutive days.
- Data collected on patient demographics, clinical status (APACHE II, SOFA scores), and specific contraindications.
Main Results:
- 70.9% of patient stays (466/657) had at least one contraindication to succinylcholine.
- Common contraindications included statin use, neuromuscular disease, acute renal failure, bedridden status, and bradycardia.
- 11.3% of stays were at high risk for hyperkalemic complications.
Conclusions:
- The high prevalence of contraindications suggests succinylcholine should be used cautiously in the ICU.
- Clinical factors associated with high complication risk include advanced age and prolonged ICU stay.
- Alternative neuromuscular blocking agents may be preferred in this population.
Keywords:
Adverse eventCritically ill patientEfecto adversoIntensive Care UnitPaciente críticoPatient safetyRapid sequence intubationSecuencia rápida de intubaciónSeguridad del pacienteSuccinilcolinaSuccinylcholineUnidad de cuidados intensivosMore Related Videos
Related Concept Videos
01:19Depolarizing Blockers: Pharmocokinetics
767
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
767
01:21Skeletal Muscle Relaxants: Adverse Effects
1.2K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.2K
01:28Depolarizing Blockers: Mechanism of Action
3.3K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.3K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
1.3K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
1.3K
01:28Cardiac Catheterization I: Pre-Procedure Overview
3.3K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.3K